Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.5.0.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2016
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule of Concentration of Revenue and Geographic Area

 

 

For the Three Months Ended June 30, 2016

 

For the Three Months Ended June 30, 2015

Licensor

 

License
Amount

 

% of Revenue

 

Licensor

 

License
Amount

 

% of Revenue

Dynamic Advances, LLC

 

$

24,900,000 

 

72%

 

Sarif Biomedical LLC

 

$

325,000 

 

24%

Orthophoenix, LLC

 

$

4,500,000 

 

13%

 

Selene Communication Technologies, LLC

 

$

150,000 

 

11%

Orthophoenix, LLC

 

$

3,750,000 

 

11%

 

E2E Processing, Inc.

 

$

140,000 

 

10%

Orthophoenix, LLC

 

$

600,000 

 

2%

 

MedTech GmbH

 

$

131,420 

 

9%

Signal IP, Inc.

 

$

310,000 

 

1%

 

E2E Processing, Inc.

 

$

120,000 

 

9%

 

 

Total

 

99%

 

 

 

Total

 

63%

 

Schedule of pending lawsuits against defendants

As of June 30, 2016, the Company is involved in a total of 18 lawsuits against defendants in the following jurisdictions:

 

United States

 

 

District of Delaware

 

5

Central District of California

 

1

Eastern District of Michigan

 

1

US Court of Appeals for the Federal Circuit

 

2

 

 

 

Foreign

 

 

Germany

 

9

 

Schedule of computation of basic and diluted earnings (loss) per share

 

 

 

 

For the Three
Months Ended
June 30, 2016

 

For the Three
Months Ended
June 30, 2015

 

For the Six
Months Ended
June 30, 2016

 

For the Six
Months Ended
June 30, 2015

Net income (loss) attributable to Marathon Patent Group, Inc. common shareholders

 

7,906,279

 

(4,502,696)

 

4,012,866

 

(9,284,267)

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

Weighted Average Common Shares - Basic

 

14,994,697

 

13,998,563

 

14,980,919

 

13,937,872

Weighted Average Common Shares - Diluted

 

16,031,564

 

13,998,563

 

16,017,786

 

13,937,872

 

 

 

 

 

 

 

 

 

Earnings (Loss) per common share:

 

 

 

 

 

 

 

 

Income (Loss) - Basic

 

$

0.53

 

$

(0.32)

 

$

0.27

 

$

(0.67)

Income (Loss) - Diluted

 

$

0.49

 

$

(0.32)

 

$

0.25

 

$

(0.67)